EMA Authorised: Zegalogue (dasiglucagon hydrochloride) — Zealand Pharma A/S

View source ↗

Summary

Zegalogue (dasiglucagon hydrochloride) has been authorised by the EMA for the treatment of Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Zegalogue (dasiglucagon)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Zealand Pharma A/S. Decision date: 19/01/2026